Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shalev

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Harefuah|September 24, 2011
[Implementing mindfulness based therapies as part of the comprehensive treatments in the Beer Sheba Mental Health Center]O Arbel, A Shalev, Z Kaplan
Hormone Research|May 6, 1998
Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy menA Shalev, R Ninnis, U Keller
American Journal of Medical Genetics. Part A|July 21, 2004
Behavioral pattern profile: a tool for the description of behavior to be used in the genetics clinicStavit A Shalev, Judith G Hall
The American Journal of Psychiatry|March 1, 1985
Rate of change in tricyclic plasma levels importantA Shalev, G Ratzoni, H Munitz
Israel Journal of Medical Sciences|December 1, 1984
B2-microglobulin levels in amniotic fluids of abnormal fetusesA Shalev, D Abeliovich, J Lieberman
Harefuah|August 1, 1985
[Panic disorder--review and update]A Shalev, H Munitz, S Tyano
American Journal of Medical Genetics. Part A|March 26, 2003
Poland anomaly--report of an unusual familyStavit A Shalev, Judith G Hall
Clinical Pharmacology and Therapeutics|November 1, 1987
The hypouricemic effect of chlorprothixeneA Shalev, H Hermesh, H Munitz
Metabolism: Clinical and Experimental|July 1, 1997
Absence of short-term effects of glucagon-like peptide-1 and of hyperglycemia on plasma leptin levels in manA Shalev, S Vosmeer, U Keller
Acta Psychiatrica Scandinavica|December 1, 1987
Severe akathisia causing neuroleptic failure: an indication for lithium therapy in schizophrenia?A Shalev, H Hermesh, H Munitz
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Harefuah|September 24, 2011
[Implementing mindfulness based therapies as part of the comprehensive treatments in the Beer Sheba Mental Health Center]O Arbel, A Shalev, Z Kaplan
Hormone Research|May 6, 1998
Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy menA Shalev, R Ninnis, U Keller
American Journal of Medical Genetics. Part A|July 21, 2004
Behavioral pattern profile: a tool for the description of behavior to be used in the genetics clinicStavit A Shalev, Judith G Hall
The American Journal of Psychiatry|March 1, 1985
Rate of change in tricyclic plasma levels importantA Shalev, G Ratzoni, H Munitz
Israel Journal of Medical Sciences|December 1, 1984
B2-microglobulin levels in amniotic fluids of abnormal fetusesA Shalev, D Abeliovich, J Lieberman
Harefuah|August 1, 1985
[Panic disorder--review and update]A Shalev, H Munitz, S Tyano
American Journal of Medical Genetics. Part A|March 26, 2003
Poland anomaly--report of an unusual familyStavit A Shalev, Judith G Hall
Clinical Pharmacology and Therapeutics|November 1, 1987
The hypouricemic effect of chlorprothixeneA Shalev, H Hermesh, H Munitz
Metabolism: Clinical and Experimental|July 1, 1997
Absence of short-term effects of glucagon-like peptide-1 and of hyperglycemia on plasma leptin levels in manA Shalev, S Vosmeer, U Keller
Acta Psychiatrica Scandinavica|December 1, 1987
Severe akathisia causing neuroleptic failure: an indication for lithium therapy in schizophrenia?A Shalev, H Hermesh, H Munitz
Pageof 20